EdiTy Therapeutics
Developing a novel immune cell-based delivery platform for intracellular therapeutic protein transfer.
About
EdiTy Therapeutics is focused on creating a groundbreaking delivery platform that leverages immune cells to transport therapeutic proteins directly to target cells within patients. This innovative technology aims to enable precise modulation of intracellular pathways involved in various diseases by delivering a range of therapeutic agents, including gene editors and immune sensors.
Technology stack
detected 2026-06-17Est. monthly stack spend~$220/mo
Email
Google Workspace
Hosting
Google Cloud
Stack
WordPress
SEO
Yoast SEO
Comments
No comments yet. Be the first to share your take.
Frequently asked
What does EdiTy Therapeutics do?
EdiTy Therapeutics is focused on creating a groundbreaking delivery platform that leverages immune cells to transport therapeutic proteins directly to target cells within patients. This innovative technology aims to enable precise modulation of intracellular pathways involved in various diseases by delivering a range of therapeutic agents, including gene editors and immune sensors.
When was EdiTy Therapeutics founded?
EdiTy Therapeutics was founded in 2020.
What industry does EdiTy Therapeutics operate in?
EdiTy Therapeutics operates in Life Sciences, Immunology, Biotech, Genome Editing, Drug Discovery, Gene Therapy.
How many employees does EdiTy Therapeutics have?
EdiTy Therapeutics has approximately 16 people on record.